Clinical trials
Phase 1 Neoplasms, Germ Cell and Embryonal trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 11 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Not yet recruiting | 1 |
| Suspended | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seattle Children's Hospital | 5 |
| Emory University | 3 |
| St. Jude Children's Research Hospital | 3 |
| AeRang Kim | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Bambino Gesù Hospital and Research Institute | 1 |
| Baylor College of Medicine | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Children's National Research Institute | 1 |
| DNAtrix, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms, Germ Cell and Embryonal | 33 |
| Glioma | 14 |
| Rhabdoid Tumor | 13 |
| Brain Neoplasms | 11 |
| Rhabdomyosarcoma | 11 |
| Sarcoma, Ewing | 11 |
| Neuroblastoma | 10 |
| Wilms Tumor | 10 |
| Osteosarcoma | 9 |
| Sarcoma | 9 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.